BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1416757)

  • 1. [Implantable insulin pump: surgical implantation under local anesthesia. (Technical note apropos of 35 cases)].
    Glock Y; Galinier P; Dalous P; Hanaire-Broutin H; Lacombe S; Lafon F; Tauber JP
    Ann Chir; 1992; 46(5):445-9. PubMed ID: 1416757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of osteomyelitis by local antibiotics using a portable electronic micropump].
    Meani E; Romanõ C
    Rev Chir Orthop Reparatrice Appar Mot; 1994; 80(4):285-90. PubMed ID: 7740128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.
    Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D
    Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The implantable insulin pump in the treatment of diabetes. Hopes and reality?].
    Vague P; Lassmann-Vague V; Belicar P; Alessis C
    Bull Acad Natl Med; 1996 Apr; 180(4):831-41; discussion 841-3. PubMed ID: 8925331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A promising alternative for the treatment of type I diabetes. The implantable insulin pump].
    Marescaux J; Vix M; Mutter D; Jeandidier N; Boivin S; Pinget M
    Chirurgie; 1993-1994; 119(9):579-84; discussion 584-5. PubMed ID: 7729209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable insulin pumps: infections most likely due to seeding from skin flora determine severe outcomes of pump-pocket seromas.
    Renard E; Rostane T; Carriere C; Marchandin H; Jacques-Apostol D; Lauton D; Gibert-Boulet F; Bringer J
    Diabetes Metab; 2001 Feb; 27(1):62-5. PubMed ID: 11240448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of abdominal location of the catheter on the efficacy of intraperitoneal insulin infusion using implantable and programmable pumps in type I diabetes.
    Pinget M; Jeandidier N; Keipes M; Louy S; Vetter A
    Transplant Proc; 1992 Jun; 24(3):945-6. PubMed ID: 1604676
    [No Abstract]   [Full Text] [Related]  

  • 8. Implantable insulin pumps: a major piece of computerized diabetes therapy.
    Selam JL
    Horm Metab Res Suppl; 1990; 24():144-54. PubMed ID: 2272620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetics treated with continuous subcutaneous insulin infusion pumps.
    Foley-Nolan D; Foley-Nolan A; Temperley D; Devlin J
    Ir Med J; 1989 Dec; 82(4):159-60. PubMed ID: 2516015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience in human diabetics with portable and implantable insulin minipumps.
    Mirouze J; Selam JL; Slingeneyer A; Chaptal PA; Hedon B; Mares P; Franetzki M; Prestele K; Millet P; Beraud JJ
    Life Support Syst; 1983; 1(1):39-49. PubMed ID: 6678370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1].
    Jarosz-Chobot P
    Wiad Lek; 2004; 57(5-6):263-6. PubMed ID: 15518073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Totally implantable venous access systems. Analysis of complications].
    D'Angelo F; Ramacciato G; Caramitti A; Aurello P; Lauro S; Bordin F; Della Casa U
    Minerva Chir; 1997; 52(7-8):937-42. PubMed ID: 9411296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trial of programmable implantable insulin pump for type I diabetes.
    Selam JL; Micossi P; Dunn FL; Nathan DM
    Diabetes Care; 1992 Jul; 15(7):877-85. PubMed ID: 1516508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fasting and postprandial plasma glucose and peripheral insulin levels in insulin-dependent diabetes mellitus and non-insulin-dependent diabetes mellitus subjects during continuous intraperitoneal versus subcutaneous insulin delivery.
    Hermans MP; van Ypersele de Strihou M; Ketelslegers JM; Squifflet JP; Buysschaert M
    Transplant Proc; 1995 Dec; 27(6):3329-30. PubMed ID: 8539974
    [No Abstract]   [Full Text] [Related]  

  • 16. Current status and future of implantable insulin pumps for the treatment of diabetes.
    Catargi B
    Expert Rev Med Devices; 2004 Nov; 1(2):181-5. PubMed ID: 16293038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Personal insulin pumps--from experiment research till recommended method of diabetes treatment].
    Mozdzan M; Ruxer J; Loba J
    Pol Merkur Lekarski; 2005 Oct; 19(112):577-9. PubMed ID: 16379330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A method for assessing catheter patency in implanted pumps for long-term intraperitoneal insulin delivery.
    Scavini M; Hammarberg B; Dosio F; Torri M; Petrella G; Galimberti G; Vai S; Fazio F; Pozza G
    Artif Organs; 1997 May; 21(5):405-8. PubMed ID: 9129773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable insulin pumps. A position statement about their clinical use.
    Renard E; Schaepelynck-Bélicar P;
    Diabetes Metab; 2007 Apr; 33(2):158-66. PubMed ID: 17300973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Course of diabetic retinopathy and metabolic control with subcutaneous insulin infusion pump: 18-month study].
    Goicolea I; Santamaría E; Pardo C; Vázquez JA; Martín A; Castresana I
    An Med Interna; 1989 Feb; 6(2):71-3. PubMed ID: 2491075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.